Biodegradable Interlayer-Crosslinked Polymer Micelles with Reduction Sensitivity for Non-Small Cell Lung Cancer...

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapeutics

Background:

• Effective cancer nanomedicines require stable circulation and targeted drug release.
• Existing nanocarriers face challenges balancing systemic stability with efficient intracellular drug delivery.

Purpose of the Study:

• To develop a novel folate-conjugated copolymer for controlled doxorubicin (DOX) delivery.
• To create reduction-sensitive micelles that improve drug retention during circulation and enable rapid release within tumor cells.

Main Methods:

• Synthesis of folate-PEG-PLG(HS)-PPhe copolymer and self-assembly into interlayer-crosslinked micelles.
• Loading of doxorubicin (DOX) into the micelles (DOX-fPGPM).
• In vitro and in vivo evaluation of drug release, stability, antitumor efficacy, and biodistribution.

Main Results:

• DOX-fPGPM micelles demonstrated enhanced stability in circulation and rapid DOX release under reductive conditions.
• Significantly improved in vitro and in vivo antitumor efficacy compared to free DOX and Doxil.
• Increased DOX accumulation in tumor tissues following intravenous injection.

Conclusions:

• The developed DOX-fPGPM nanomedicine effectively balances systemic stability and targeted intracellular drug release.
• This nanocarrier platform shows significant promise for improving cancer therapy outcomes.
• The design offers a potential solution to the critical challenge in nanomedicine delivery.